95 related articles for article (PubMed ID: 26768954)
41. Comment on the article "Outcome of surgically treated octogenarians with breast cancer".
Belli AK; Memis G; Dere O; Nazli O
J Postgrad Med; 2015; 61(2):144. PubMed ID: 25766358
[No Abstract] [Full Text] [Related]
42. [A Case of Advanced Breast Cancer in an Elderly Patient That Was Well Controlled by Mohs' Paste, Endocrine Therapy, and Denosumab].
Okumura K; Yabe S; Shimokuni T; Nishikawa M; Miyazaki M; Suzuki T; Nakagawa T; Takahashi M
Gan To Kagaku Ryoho; 2019 Feb; 46(2):336-338. PubMed ID: 30914552
[TBL] [Abstract][Full Text] [Related]
43. Patients electing to have PET rather than surgery for operable breast cancer are a high risk of treatment failure.
Thomas R; Rowell R; Crichton S; Cain H
Breast Cancer Res Treat; 2018 Dec; 172(3):597-601. PubMed ID: 30159785
[TBL] [Abstract][Full Text] [Related]
44. Definition of First-Line Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer.
Reinert T; Barrios CH
J Clin Oncol; 2016 Jun; 34(16):1959-60. PubMed ID: 27001564
[No Abstract] [Full Text] [Related]
45. Challenges in the diagnosis of breast cancer in the elderly.
Belli AK; Memis G; Dere O; Nazli O
J Postgrad Med; 2015; 61(3):211. PubMed ID: 26119445
[No Abstract] [Full Text] [Related]
46. Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.
Colleoni M; Sun Z; Price KN; Karlsson P; Forbes JF; Thürlimann B; Gianni L; Castiglione M; Gelber RD; Coates AS; Goldhirsch A
J Clin Oncol; 2016 Mar; 34(9):927-35. PubMed ID: 26786933
[TBL] [Abstract][Full Text] [Related]
47. Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: Work in progress.
Rubio IT
Eur J Surg Oncol; 2016 Mar; 42(3):326-32. PubMed ID: 26774943
[TBL] [Abstract][Full Text] [Related]
48. Fertility Preservation for the Young Breast Cancer Patient.
Goldfarb SB; Kamer SA; Oppong BA; Eaton A; Patil S; Junqueira MJ; Olcese C; Kelvin JF; Gemignani ML
Ann Surg Oncol; 2016 May; 23(5):1530-6. PubMed ID: 26790670
[TBL] [Abstract][Full Text] [Related]
49. Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care.
Thompson ER; Rowley SM; Li N; McInerny S; Devereux L; Wong-Brown MW; Trainer AH; Mitchell G; Scott RJ; James PA; Campbell IG
J Clin Oncol; 2016 May; 34(13):1455-9. PubMed ID: 26786923
[TBL] [Abstract][Full Text] [Related]
50. Neoadjuvant endocrine treatment in early breast cancer: An overlooked alternative?
van Dam PA; van Dam VC; Altintas S; Papadimitriou K; Rolfo C; Trinh XB
Eur J Surg Oncol; 2016 Mar; 42(3):333-42. PubMed ID: 26776766
[TBL] [Abstract][Full Text] [Related]
51. The impact of mammographic screening on the surgical management of breast cancer.
James TA; Wade JE; Sprague BL
J Surg Oncol; 2016 Apr; 113(5):496-500. PubMed ID: 26799535
[TBL] [Abstract][Full Text] [Related]
52. Validity of the online PREDICT tool in older patients with breast cancer: a population-based study.
de Glas NA; Bastiaannet E; Engels CC; de Craen AJ; Putter H; van de Velde CJ; Hurria A; Liefers GJ; Portielje JE
Br J Cancer; 2016 Feb; 114(4):395-400. PubMed ID: 26783995
[TBL] [Abstract][Full Text] [Related]
53. Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.
Zdenkowski N; Forbes JF; Boyle FM; Kannourakis G; Gill PG; Bayliss E; Saunders C; Della-Fiorentina S; Kling N; Campbell I; Mann GB; Coates AS; Gebski V; Davies L; Thornton R; Reaby L; Cuzick J; Green M;
Ann Oncol; 2016 May; 27(5):806-12. PubMed ID: 26861603
[TBL] [Abstract][Full Text] [Related]
54. Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer.
Tucker NS; Cyr AE; Ademuyiwa FO; Tabchy A; George K; Sharma PK; Jin LX; Sanati S; Aft R; Gao F; Margenthaler JA; Gillanders WE
Ann Surg; 2016 Dec; 264(6):1098-1102. PubMed ID: 26779976
[TBL] [Abstract][Full Text] [Related]
55. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Silvestri V; Barrowdale D; Mulligan AM; Neuhausen SL; Fox S; Karlan BY; Mitchell G; James P; Thull DL; Zorn KK; Carter NJ; Nathanson KL; Domchek SM; Rebbeck TR; Ramus SJ; Nussbaum RL; Olopade OI; Rantala J; Yoon SY; Caligo MA; Spugnesi L; Bojesen A; Pedersen IS; Thomassen M; Jensen UB; Toland AE; Senter L; Andrulis IL; Glendon G; Hulick PJ; Imyanitov EN; Greene MH; Mai PL; Singer CF; Rappaport-Fuerhauser C; Kramer G; Vijai J; Offit K; Robson M; Lincoln A; Jacobs L; Machackova E; Foretova L; Navratilova M; Vasickova P; Couch FJ; Hallberg E; Ruddy KJ; Sharma P; Kim SW; ; Teixeira MR; Pinto P; Montagna M; Matricardi L; Arason A; Johannsson OT; Barkardottir RB; Jakubowska A; Lubinski J; Izquierdo A; Pujana MA; Balmaña J; Diez O; Ivady G; Papp J; Olah E; Kwong A; ; Nevanlinna H; Aittomäki K; Perez Segura P; Caldes T; Van Maerken T; Poppe B; Claes KB; Isaacs C; Elan C; Lasset C; Stoppa-Lyonnet D; Barjhoux L; Belotti M; Meindl A; Gehrig A; Sutter C; Engel C; Niederacher D; Steinemann D; Hahnen E; Kast K; Arnold N; Varon-Mateeva R; Wand D; Godwin AK; Evans DG; Frost D; Perkins J; Adlard J; Izatt L; Platte R; Eeles R; Ellis S; ; Hamann U; Garber J; Fostira F; Fountzilas G; Pasini B; Giannini G; Rizzolo P; Russo A; Cortesi L; Papi L; Varesco L; Palli D; Zanna I; Savarese A; Radice P; Manoukian S; Peissel B; Barile M; Bonanni B; Viel A; Pensotti V; Tommasi S; Peterlongo P; Weitzel JN; Osorio A; Benitez J; McGuffog L; Healey S; Gerdes AM; Ejlertsen B; Hansen TV; Steele L; Ding YC; Tung N; Janavicius R; Goldgar DE; Buys SS; Daly MB; Bane A; Terry MB; John EM; Southey M; Easton DF; Chenevix-Trench G; Antoniou AC; Ottini L
Breast Cancer Res; 2016 Feb; 18(1):15. PubMed ID: 26857456
[TBL] [Abstract][Full Text] [Related]
56. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping.
Niebling MG; Pleijhuis RG; Bastiaannet E; Brouwers AH; van Dam GM; Hoekstra HJ
Eur J Surg Oncol; 2016 Apr; 42(4):466-73. PubMed ID: 26853759
[TBL] [Abstract][Full Text] [Related]
57. Inferring the Effects of Cancer Treatment: Divergent Results From Early Breast Cancer Trialists' Collaborative Group Meta-Analyses of Randomized Trials and Observational Data From SEER Registries.
Henson KE; Jagsi R; Cutter D; McGale P; Taylor C; Darby SC
J Clin Oncol; 2016 Mar; 34(8):803-9. PubMed ID: 26786924
[TBL] [Abstract][Full Text] [Related]
58. Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects.
Abdel-Razeq H; Abu Rous F; Abuhijla F; Abdel-Razeq N; Edaily S
Clin Interv Aging; 2022; 17():1445-1460. PubMed ID: 36199974
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant Treatment of Elderly Breast Cancer Patients: Offer the Best Chances of Cure.
Marinopoulos S; Dimitrakakis C; Kalampalikis A; Zagouri F; Andrikopoulou A; Rodolakis A
Breast Care (Basel); 2022 Feb; 17(1):71-80. PubMed ID: 35355693
[TBL] [Abstract][Full Text] [Related]
60. De-escalating axillary surgery in early-stage breast cancer.
Hersh EH; King TA
Breast; 2022 Mar; 62 Suppl 1(Suppl 1):S43-S49. PubMed ID: 34949533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
